SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1419<<The best way to play a scientific discovery at Millennium is probably byMiljenko Zuanic-3/13/2003
1418I'm not sure how Robert Green can conclude that a 5% investment in MLNM makeIan@SI-3/13/2003
1417It came across the wires yesterday, shortly before I posted it. Cheers, Tucktuck-3/13/2003
1416Tuck - what is the date on this news? can't find it in recent news.. Thnx, Michael Hart-3/13/2003
1415>>WASHINGTON (Dow Jones)--Abbott Laboratories Inc. has a 5.3% stake in Miltuck-3/12/2003
1414An interesting article ... ---- >>With rare exceptions, the treatment ofmicrocapfun-3/12/2003
1413buy debt with cash on the market for less than face value?sammaster-3/11/2003
1412Ice, This seems to answer the question. Millennium Up as FDA Says to Review DruIRWIN JAMES FRANKEL-3/10/2003
1411Talking to myself >>The FDA expedites the approval process for such an NDIcebrg-3/10/2003
1410FDA Accepts for Review NDA Filing and Grants Priority Review for VELCADE(TM) (boIcebrg-3/10/2003
1409If the stock actually pops (other than a brief transient response) in mid-March Londo-3/6/2003
1408>>Bioorganic & Medicinal Chemistry Letters Volume 13, Issue 3 , 10 Femicrocapfun-3/5/2003
1407Nadine Wong Profiles the Following Stocks: Millennium and Celgene CHICAGO, Mabob zagorin-3/5/2003
1406>>If the FDA accepts the application for filing that will be an indirect imicrocapfun-3/4/2003
1405Circulation. 2003;107:1123. © 2003 American Heart Association, Inc. -----Miljenko Zuanic-3/3/2003
1404Millennium Pharm Grants CEO 200,000 Stock Options DOW JONES NEWSWIRES WASHINGTbob zagorin-3/3/2003
1403Rocky, you're right. Sorry, I've been using the word "debt" wLondo-3/2/2003
1402I am not sure that you are right about how MLNM accounts for the increase in theRocky9-3/1/2003
1401This scenario is valid, but is inconsistent with Kalian's statement saying tLondo-3/1/2003
1400<<The company expects to have $1.3 billion in cash at the end of the year,Rocky9-3/1/2003
139922% is huge dilution, and I am against conversion to shares at this level. What Miljenko Zuanic-2/27/2003
1398<i>The company expects to have $1.3 billion in cash at the end of the yearLondo-2/27/2003
1397Millenium Pharma: On Track For $500M '05 Integrilin Sales DOW JONES NEWSWIRbob zagorin-2/27/2003
1396EMEA Accepts Marketing Authorization Application For Bortezomib (VELCADE(TM)) 3.Icebrg-2/25/2003
1395Research and Markets: PharmaVitae 2002: Millennium Pharmaceuticals Feb 23, 20bob zagorin-2/24/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News